
Dr. Reddy’s shares upgraded by Citi after three years, target raised; Stock gains
Citi said the acceptance of Abatacept indicated the most challenging development and biosimilar hurdles were behind for the company in terms of the biological license…

Citi said the acceptance of Abatacept indicated the most challenging development and biosimilar hurdles were behind for the company in terms of the biological license…

Enigma Investment Partners CIO Viraj Mehta expects strong Q2FY27 earnings for small and midcaps, sees consumer stocks benefiting from inflation and remains cautious on IT…

Goldman Sachs said it remains positive on IndiGo’s growth outlook, citing the airline’s consistent market share gains, favourable industry capacity dynamics, cost leadership and the…

Silver prices fell on Sept 29, extending Monday’s sharp decline. MCX December silver traded at ₹2.25 lakh per kg, down 0.93%, amid a stronger US…

In an interaction with CNBC-TV18, Hetal Dalal of IiAS said that the move that the Tata Trusts has made will now depend on the RBI…

JPMorgan said NBFCs continue to gain market share in both the housing finance and gold loan segments. On asset quality, the brokerage said conditions remain…

The Chief Investment Officer advises investors to focus on asset allocation and hybrid funds, while identifying the insurance sector as a prime contrarian opportunity.

Of the nine analysts who have coverage on the Azad Engineering stock, eight have a “buy” recommendation and one has a “sell” rating.

At the end of the June quarter, promoter Jupiter Capital Pvt. Ltd. held 58.04% stake in the company while public shareholding comprised of 41.97%.

Mayuresh Joshi, Director Research, Marketsmith India, discussed why valuations matter after Honasa’s sharp rally, shared his outlook on metals, refiners and Vodafone Idea, and explained…